www.fdanews.com/articles/187411-kent-imaging-and-serenagroup-team-up-to-improve-wound-tissue-assessment
Kent Imaging and SerenaGroup Team Up to Improve Wound Tissue Assessment
June 28, 2018
Kent Imaging and SerenaGroup announced a strategic partnership to develop techniques to assess tissue in wounds using one of Kent Imaging’s devices.
The device, the KD203, uses near infrared imaging technology to perform non-invasive to capture diagnostics about oxygenated blood availability in tissue.
The device measures oxygen saturation, relative oxyhemoglobin levels and relative deoxyhemoglobin levels in superficial tissue, using color-coded images to provide critical information about the tissue.